Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV774
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,504
Award facts
- Contract value 100% obligated
- $56,503.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $56,503.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegtibatase alfa), a complement inhibitor medication, in 1,100 mg/11 mL vial format. This firm fixed-price contract, issued on January 22, 2026, with ultimate completion scheduled for February 12, 2026, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support for military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The award demonstrates the contractor's capability to meet federal procurement requirements through competitive bidding and reflects its established role as a primary vendor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV774?
SPE2DR26FV774 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FV774 worth?
The government has obligated $56,504 on SPE2DR26FV774.
Is contract SPE2DR26FV774 an order under another contract?
Yes. SPE2DR26FV774 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV774 competed?
The extent of competition for SPE2DR26FV774 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award